LeBlanc, R. et al. 2018. CANADIAN COST ANALYSIS COMPARING MAINTENANCE THERAPY WITH BORTEZOMIB VERSUS LENALIDOMIDE FOR PATIENTS WITH MULTIPLE MYELOMA POST AUTOLOGOUS STEM CELL TRANSPLANT. Journal of Population Therapeutics and Clinical Pharmacology. 23, 1 (Nov. 2018).